Skip to content

Clinical trials

Respiratory Tract Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20174
20191
20201
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Recruiting3
Active, not recruiting2
Completed2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Hoffmann-La Roche2
ArriVent BioPharma, Inc.1
AstraZeneca1
Blueprint Medicines Corporation1
Daiichi Sankyo1
Revolution Medicines, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms12
Respiratory Tract Neoplasms12
Carcinoma, Non-Small-Cell Lung11
Lung Diseases11
Respiratory Tract Diseases11
Bronchial Neoplasms10
Neoplasms by Site10
Thoracic Neoplasms10
Neoplasms9
Carcinoma, Bronchogenic8

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.